This study aims at developing Reminiscence Function Scale-Short Form(RFS-S) and verifying it as a supplemental diagnosis instrument to judge differences between normal and mild cognitive impairment and useful measure to rate effects of reminiscence therapy in the clinical field through internal consistency reliability and criterion validity. The study also aims at figuring out factors affection reminiscence function by figuring out demographic features of RFS-S. The research subjects were the control group of 60 normal people and experimental group of 58 people with mild cognitive impairment and both groups were over 65 years old. For internal consistency reliability(Cronbach's alpha) between questions was reliable with 0.63. Convergent validities of RFS-S with SRT and CDR-SB were 0.20(p<.05) and -0.25(p<.001), respectively, as both showed significant correlations. As a result of criterion validity to analyze AUROC, it was 0.68(p<.001) and less accurate. Its optimal cut-off points were 17 and sensitivity according to them was 0.59, and specificity was 0.72, respectively. However, reminiscence function according to demographic variables did not show any significant differences. Therefore, it is expected that RFS-S will be used as a supplemental diagnosis instrument with higher reliability and validity for discerning differences between normal and mild cognitive impairment and as a useful one to verify effects of reminiscence therapy.
Ⅲ. 연구결과 
대상자의 일반적 특성 및 사전 동질성 검증

그림 1. RFS-S의 ROC curve
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